Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1965 2
1966 1
1967 1
1968 2
1970 2
1971 2
1981 1
1983 1
1986 1
1987 2
1988 2
1989 1
1991 1
1992 2
1993 1
1994 2
1995 1
1996 2
1997 4
1999 9
2000 4
2001 15
2002 11
2003 13
2004 38
2005 32
2006 41
2007 42
2008 44
2009 38
2010 51
2011 61
2012 59
2013 46
2014 65
2015 61
2016 49
2017 52
2018 48
2019 55
2020 68
2021 60
2022 66
2023 52
2024 76
2025 34

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,050 results

Results by year

Filters applied: . Clear all
Page 1
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2.
Rondi P, Mattavelli D, Rampinelli V, Schreiber A, Orlandi E, Vischioni B, Iacovelli NA, Calareso G, Bergamini C, Alfieri S, Castelnuovo P, Battaglia P, Turri-Zanoni M, Nicolai P, Ferrari M, Licitra L, Bossi P, Farina D, Ravanelli M, Resteghini C. Rondi P, et al. Among authors: farina d. Oral Oncol. 2025 Jul;166:107388. doi: 10.1016/j.oraloncology.2025.107388. Epub 2025 May 25. Oral Oncol. 2025. PMID: 40418879 Clinical Trial.
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial.
Dalla Volta A, Valcamonico F, Zivi A, Procopio G, Sepe P, Del Conte G, Di Meo N, Foti S, Zamboni S, Messina C, Lucchini E, Rizzi A, Ravanelli M, Calza S, Zacchi F, Ciccone G, Suardi N, Maroldi R, Farina D, Berruti A. Dalla Volta A, et al. Among authors: farina d. Prostate Cancer Prostatic Dis. 2025 May 3. doi: 10.1038/s41391-025-00975-8. Online ahead of print. Prostate Cancer Prostatic Dis. 2025. PMID: 40319177
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study.
Buffoni M, Dalla Volta A, Valcamonico F, Bergamini M, Caramella I, D'Apollo D, Zivi A, Procopio G, Sepe P, Del Conte G, Di Meo N, Foti S, Zamboni S, Messina C, Lucchini E, Maroldi R, Laganà M, Ravanelli M, Zamparini M, Zacchi F, Suardi N, Farina D, Berruti A. Buffoni M, et al. Among authors: farina d. Eur Urol Oncol. 2025 Jun;8(3):782-791. doi: 10.1016/j.euo.2025.02.006. Epub 2025 Apr 28. Eur Urol Oncol. 2025. PMID: 40300921 Free article. Clinical Trial.
Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapy.
Guerini AE, Buglione M, Nici S, Riga S, Pegurri L, Mataj E, Farina D, Ravanelli M, Rondi P, Cossali G, Tomasini D, Triggiani L, Facheris G, Spiazzi L, Magrini SM. Guerini AE, et al. Among authors: farina d. Clin Transl Radiat Oncol. 2025 Mar 25;53:100950. doi: 10.1016/j.ctro.2025.100950. eCollection 2025 Jul. Clin Transl Radiat Oncol. 2025. PMID: 40231325 Free PMC article.
Nodal status in major salivary gland cancer: External validation of a novel N- classification.
Lombardi D, Tomasoni M, Missale F, Smeele LE, Van Lierde C, Van Eecke M, Pellini R, Mazzola F, Ravanelli M, Farina D, Clark J, Low TH, Gupta R, Fleming JC, Ghazal-Asswad R, Locati L, Filauro M, Peretti G, Patel S, Gagliardini L, Bossi P, Poorten VV, Piazza C. Lombardi D, et al. Among authors: farina d. Eur J Surg Oncol. 2025 Apr 1;51(8):110006. doi: 10.1016/j.ejso.2025.110006. Online ahead of print. Eur J Surg Oncol. 2025. PMID: 40194336
1,050 results